November 30, 2012—Legislation that aims to address drug shortages by exempting manufacturers from providing 340B discounts on certain pharmaceuticals has been introduced in the U.S. House.
Rep. Bill Cassidy (R-La.), a member of the House Energy and Commerce Subcommittee on Health, introduced the Patient Access to Drugs in Shortage Act (H.R. 6611) late yesterday.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)